Cas:5197-95-5 Benzyltriethylammonium Bromide manufacturer & supplier

Chemical Name:Benzyltriethylammonium Bromide

CAS.NO:5197-95-5

Synonyms:MFCD00011822;Benzyltriethylammonium bromide;benzyl(triethyl)azanium,bromide;Benzyl triethyl ammonium bromide (TEBA);N-Benzyl-N,N-diethylethanaminium bromide;EINECS 225-986-1

Molecular Formula:C₁₃H₂₂BrN

Molecular Weight:272.224

HS Code:2827590000

Physical and Chemical Properties:

Melting point:193-195 °C (dec.)(lit.)

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:271.093567

LogP:0.06710

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2811

Packing Group:

Contact us for information like MFCD00011822 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 225-986-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Benzyl-N,N-diethylethanaminium bromide Use and application,MFCD00011822 technical grade,usp/ep/jp grade.

Related News: Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. Benzyltriethylammonium Bromide manufacturer Fears over the continuing spread of coronavirus have also fueled resentment and discrimination. Some have become outcasts in their own country, shunned by hotels, neighbors and — in some areas — placed under controversial quarantine measures. Benzyltriethylammonium Bromide supplier At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. Benzyltriethylammonium Bromide vendor The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful. Benzyltriethylammonium Bromide factory At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.